ReviewBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2020
Potential Role of Anti-interleukin (IL)-6 Drugs in the Treatment of COVID-19: Rationale, Clinical Evidence and Risks.
Salvatore Crisafulli et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
41 papers cite it
this paperpooled ittrialcites it